Nectar Lifesciences Limited

Overview

Nectar Lifesciences Limited is a leading pharmaceutical company in India, focusing on the manufacture of APIs, finished dosage forms, and phytochemicals. The company serves clients worldwide, catering to various therapeutic areas with its diverse product portfolio.

Therapeutic areas

API / Drug Master Files

Nectar Lifesciences Limited holds 18 active (19 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• CEFPODOXIME PROXETIL USPActive2014-06-14
• CEFTAZIDIME FOR INJECTION USP (STERILE BULK)Active2012-11-16
• CEFEPIME FOR INJECTION USP (STERILE BULK) DRUG SUBSTANCEActive2012-05-05
• CEFTRIAXONE SODIUM USP (STERILE) DRUG SUBSTANCE (PROCESS-II)Active2012-05-02
• CEFEPIME HYDROCHLORIDE USP (STERILE)Active2012-02-21
• CEFDINIR USPActive2011-12-29
• CEFEPIME HYDROCHLORIDE (NON-STERILE)Active2011-12-22
• PYCA (NON-STERILE DRUG SUBSTANCE INTERMEDIATE)Active2011-10-08
• CEFOTAXIME SODIUM USP (STERILE) DRUG SUBSTANCEActive2011-03-10
• CEFUROXIME SODIUM USP (STERILE) DRUG SUBSTANCEActive2011-01-31
• CEFOTAXIME (NON STERILE DRUG SUBSTANCES INTERMEDIATE)Active2010-10-30
• CEFTRIAXONE SODIUM USP (STERILE) DRUG SUBSTANCEActive2010-10-30
• CEFTRIAXONE SODIUM (NON-STERILE) DRUG SUBSTANCEActive2010-08-31
• 7-AMINO-3-VINYL-3-CEPHEM-4-CARBOXYLIC ACID (7-AVCA) [NON-STERILE DRUG SUBSTANCE INTERMEDIATE]Active2009-12-31
• CEFUROXIME AXETIL USP (AMORPHOUS)Active2009-01-21

Showing 15 of 19 Drug Master Files.

FDA compliance signals